Complete guide to cannabis laws, penalties, and travel advice
| Legal Status | Completely Illegal |
| Medical Cannabis | None — no program exists on mainland |
| Possession Penalty | Detention, fines, up to 3 years compulsory rehabilitation; criminal prosecution for larger amounts |
| Trafficking Penalty | 7 years to life imprisonment; death penalty for amounts exceeding thresholds (50g+ heroin equivalent) |
| Traveler Risk | Extreme — Zero Tolerance, Mandatory Testing, Social Credit Implications |
China maintains one of the world's most absolute prohibitions on cannabis. Under the Law on Penalties for Administration of Public Security (治安管理处罚法) and the Narcotics Control Law (禁毒法), cannabis is classified as a narcotic substance alongside heroin, methamphetamine, and cocaine. There is no distinction in law between recreational and medicinal use at the consumer level, and no pathway exists for personal authorization.
The legal framework governing drugs in China rests on several overlapping statutes. The Criminal Law of the People's Republic of China (Articles 347–357) establishes penalties for drug-related crimes including manufacture, trafficking, transportation, and possession. The Narcotic Drugs and Psychotropic Substances Regulations control pharmaceutical use. For cannabis specifically, the substance appears on Schedule I of the Narcotic Drugs Control List, effectively placing it in the highest restriction category with no recognized therapeutic value at the consumer level.
China's approach to cannabis prohibition dates to the early twentieth century, influenced by international treaties and domestic anti-opium campaigns. The Communist government that took power in 1949 pursued aggressive anti-drug campaigns, largely eradicating both opium and cannabis use through mass campaigns in the 1950s and 1960s. The Mao-era prohibition left a cultural legacy that deeply shapes enforcement attitudes today.
Despite absolute prohibition of consumer cannabis, China is paradoxically the world's largest producer of industrial hemp. Provinces including Yunnan, Heilongjiang, and Inner Mongolia license large-scale hemp cultivation for fiber, seeds, and certain industrial extracts. This hemp industry operates under strict licensing, with THC content limits and harvest protocols monitored by agricultural authorities. The tension between industrial hemp production and consumer prohibition creates legal complexity around CBD and hemp-derived products.
Chinese drug law operates on a tiered penalty system based on quantity, prior offenses, and the role of the individual (user, small dealer, or trafficker). For cannabis specifically, the practical enforcement thresholds work as follows:
| Quantity / Situation | Legal Category | Potential Penalty |
|---|---|---|
| Trace amounts / personal use | Administrative offense | 10–15 days detention, fine up to ¥2,000, mandatory drug testing |
| Small amounts (under 200g cannabis) | Minor criminal offense | Up to 3 years compulsory rehabilitation center; possible criminal prosecution |
| Repeat offender, any amount | Criminal prosecution | 3–7 years imprisonment, substantial fines |
| 200g–1,000g cannabis | Drug trafficking / serious offense | 7–15 years imprisonment |
| Over 1,000g cannabis (or 50g heroin equivalent) | Large-scale drug trafficking | 15 years to life imprisonment or death penalty |
| Organization of drug use on premises | Aggravated offense | 3–7 years minimum; enhanced if minors involved |
A critical aspect of Chinese drug law is the use of drug rehabilitation camps. The "Compulsory Isolated Drug Treatment" (强制隔离戒毒) system allows police to detain suspected drug users for up to two years without a court order, with an additional year possible. This administrative detention sidesteps criminal prosecution, meaning users can face significant deprivation of liberty without ever appearing before a judge. Human rights organizations including Amnesty International and Human Rights Watch have documented abuses within these facilities.
Mandatory drug testing is another enforcement tool that foreign visitors rarely anticipate. Police in major cities and tourist areas conduct random urine tests. Even if the person consumed cannabis legally in another country days or weeks before arrival, a positive test result in China can trigger the full enforcement apparatus. THC metabolites can remain detectable in urine for 30–45 days in regular users.
There is no legal medical cannabis program in mainland China. Cannabis is not recognized as having therapeutic value under Chinese pharmaceutical regulations. Unlike many countries that have carved out exceptions for CBD-based medicines (such as Epidiolex for epilepsy), China has not approved any cannabis-derived pharmaceutical for clinical use.
Traditional Chinese medicine (TCM) has a long historical relationship with cannabis. The plant "da ma" (大麻) is referenced in classical medical texts including the Shennong Bencao Jing (Divine Farmer's Materia Medica), a foundational TCM pharmacopeia dating from approximately 100 CE. Seeds (火麻仁) are still used in TCM practice for their laxative properties and are legally sold in herbal medicine shops. However, the flower, leaves, and resin containing THC or CBD in significant quantities remain prohibited regardless of claimed therapeutic purpose.
Researchers at Chinese universities have conducted significant scientific work on cannabinoids, and China holds a large number of cannabis-related patents globally. This scientific engagement has not translated into any consumer or patient access. The regulatory path for cannabis-based medicines remains effectively closed.
Personal cultivation of cannabis is absolutely illegal in China. Any cultivation of plants containing THC above trace levels (the industrial hemp threshold is typically 0.3% THC) constitutes a criminal offense and is treated with the same severity as possession or trafficking, scaled by the potential yield of the plants involved.
Industrial hemp cultivation is legal but tightly controlled. Licensed operations in Yunnan, Heilongjiang, Inner Mongolia, and a small number of other provinces can grow low-THC hemp. These operations are primarily for textile fiber, hempseed oil (used in food and cosmetics), and certain industrial applications. Licensing requires government authorization, and the crop is subject to periodic testing and inspection. Growing hemp without a license is prosecuted as cannabis cultivation.
China's hemp industry is significant globally. Yunnan province alone produces a substantial share of the world's hemp biomass. Chinese hemp fiber appears in textiles sold worldwide. However, this industrial presence does not create any legal gray area for individual growers — unlicensed cultivation, even of apparent hemp varieties, is prosecuted aggressively.
China's position geographically between the Golden Triangle (Myanmar, Laos, Thailand) drug production region and major consumer markets makes trafficking prosecution a national security priority. The government deploys significant law enforcement resources along borders with Myanmar, Laos, and Vietnam. Cross-border trafficking operations are treated as organized crime matters, frequently involving multiple agencies including local police, the Ministry of State Security, and military units in border regions.
High-profile trafficking cases in China regularly result in public executions. The country is believed to execute more people for drug crimes annually than all other nations combined, though exact figures are classified. Amnesty International estimates hundreds of drug-related executions take place each year. Foreign nationals have been executed for drug trafficking in China, including cases involving cannabis trafficking at commercial scale.
The law mandates the death penalty when trafficking quantities meet statutory thresholds. For cannabis, the critical weight is 1,000 grams (1 kilogram) of cannabis plant material. Concentrates and resins are calculated differently — a small quantity of cannabis oil or hash with equivalent THC content to over a kilogram of plant material could potentially trigger the same penalty threshold. Courts have applied the death penalty in cases involving significantly smaller apparent quantities when extracts or concentrates were involved.
Cannabis has a history in China spanning thousands of years. Archaeological evidence from Jirzankal Cemetery in western China (present-day Xinjiang) suggests ritualistic use of cannabis for its psychoactive properties approximately 2,500 years ago. Scholars have linked this early use to the Sogdian and Scythian peoples who inhabited the region. The charred remains of cannabis with elevated THC content found at the site suggest intentional cultivation of psychoactive varieties, not just fiber hemp.
Classical Chinese literature references cannabis in contexts ranging from agriculture and fiber production to medicine and ritual. The Han dynasty text Shu Wen distinguishes between male cannabis (used for fiber) and female cannabis (used medicinally). Li Shizhen's monumental Bencao Gangmu (Compendium of Materia Medica, 1596) catalogues cannabis applications in detail while also noting its intoxicating properties and cautioning against overuse.
The transition from traditional use to prohibition accelerated in the nineteenth and early twentieth centuries as China grappled with the devastating social impact of opium — a crisis largely created by British colonial policy. Anti-drug sentiment became intertwined with national sovereignty and anti-colonial politics. The Communist revolution of 1949 brought comprehensive prohibition campaigns. By the mid-1950s, drug use had been largely suppressed through a combination of treatment campaigns, social pressure, and harsh punishment. The Cultural Revolution (1966–1976) reinforced moral prohibition of intoxicants across the board.
Today, cannabis use within China is largely a phenomenon of major cities, among younger, internationally exposed populations. Social media, particularly platforms accessible via VPN, has exposed Chinese youth to global cannabis culture. However, enforcement remains vigorous. The government runs periodic anti-drug campaigns, mass testing events, and uses cannabis prohibition as a component of the broader social credit and social stability apparatus.
For travelers to China, the cannabis risk calculus is stark: any involvement with cannabis before or during your visit creates serious legal risk that can upend your trip and your life. The following practical points represent the consensus advice from harm reduction organizations, travel lawyers, and embassy briefings.
Do not bring cannabis into China. This applies to any form — flower, edibles, vapes, oils, tinctures, or CBD products. Chinese customs and border authorities conduct thorough checks, including x-ray, sniffer dogs, and random searches. Diplomatic immunity does not protect non-diplomatic travelers. Even CBD products that are legal in your home country constitute a cannabis-derived substance under Chinese law.
Be aware of mandatory testing. Police in China can require you to undergo a urine drug test without a warrant. If you have consumed cannabis (even legally) in the weeks before arriving in China, THC metabolites may still be detectable. A positive test in China is treated as evidence of drug use regardless of where the use occurred. This has caught numerous unsuspecting foreign visitors.
Hotel room searches are common. Chinese police regularly conduct checks of hotel rooms, particularly in areas with high tourist or expatriate populations. Room searches do not require a warrant under Chinese law as applied in practice. Items found in your room are your legal responsibility.
The social credit system creates additional stakes. Drug offenses in China feed into the social credit system, which can restrict access to transportation, housing, financial services, and employment. For foreign nationals, a drug record creates an effective permanent ban on future Chinese visas and travel. The consequences extend beyond the immediate legal penalty.
Hong Kong has a separate but still strict regime. Hong Kong's Dangerous Drugs Ordinance classifies cannabis as a dangerous drug. Possession carries up to 7 years imprisonment; trafficking up to life imprisonment. While Hong Kong's legal system is more procedurally similar to common law jurisdictions (right to legal representation, court proceedings), the substantive penalties are still severe. Do not assume Hong Kong's relative cosmopolitanism reflects cannabis tolerance.
Macau similarly prohibits cannabis. The special administrative region of Macau, while famous for its casinos and more internationally oriented atmosphere, fully prohibits cannabis under its own drug laws derived from Portuguese legal traditions. Enforcement is active.
China's cannabis policy has shown no meaningful liberalization trend. If anything, enforcement capacity has increased with technology. Facial recognition, mass surveillance infrastructure, and data-sharing between agencies make detection more likely than in previous decades. International drug enforcement cooperation under the UN conventions also means that drug records from China can follow individuals internationally.
The government's position on cannabis was reaffirmed through its handling of the 2020–2021 CBD regulatory clarification, when authorities explicitly declined to follow the trajectory of CBD liberalization seen in the United States, EU, and UK. China's National Medical Products Administration stated clearly that CBD was not approved for food or cosmetic use, effectively shutting down the small domestic CBD consumer market that had been developing.
Industrial hemp policy has continued to evolve with China expanding its hemp cultivation footprint globally, including through Belt and Road Initiative investments in hemp-growing in partner countries. However, this commercial expansion has zero bearing on domestic consumer policy.
Chinese pharmaceutical companies have invested in cannabinoid research, and several hold patents on cannabinoid-based formulations. It is plausible that China will eventually develop a regulated market for specific pharmaceutical cannabinoids. This trajectory, if it occurs, would likely follow the narrow pharmaceutical model rather than any consumer legalization pathway, and it remains speculative for the foreseeable future.
For travelers and expats, the single most important policy development to track is any change in how China handles foreign nationals caught with cannabis — specifically whether the standard response shifts from deportation-after-prosecution toward immediate deportation or toward harsher prosecution. At present, most foreign nationals caught with small personal amounts are prosecuted, detained in rehabilitation or pretrial facilities, and then deported. However, this can mean weeks or months of detention before resolution.
No. Cannabis is completely illegal in China for any purpose, including possession, use, cultivation, and trafficking. There is no medical cannabis program on the mainland. The penalties are among the harshest in the world, with trafficking large quantities potentially resulting in the death penalty.
Possession of any amount can result in detention, fines, mandatory drug rehabilitation (compulsory treatment centers for up to 3 years), and prison sentences. Foreign nationals are typically deported after serving a sentence. There are also serious social credit system implications that can restrict travel, banking, and employment opportunities.
CBD is a deeply gray area in China. Hemp cultivation for fiber and seeds is permitted in certain provinces, but CBD oil products marketed for human consumption face heavy restrictions. The National Medical Products Administration has clarified that CBD is not approved as a food or cosmetic ingredient, making most CBD consumer products technically illegal.
Hong Kong operates under a separate legal system (one country, two systems), but cannabis remains illegal there as well. The Dangerous Drugs Ordinance classifies cannabis as a dangerous drug. Penalties in Hong Kong include up to 7 years imprisonment for possession and up to life imprisonment for trafficking, making enforcement strict though somewhat less extreme than mainland China in practice.